TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1 — Class II drug recall D-0176-2022
Terminated recall by Vita Pharmacy, LLC dba Talon Compounding Pharmacy, reported 2021-11-17, distributed in PR, WA. Lack of assurance of sterility
| Recall number | D-0176-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Vita Pharmacy, LLC dba Talon Compounding Pharmacy, San Antonio, TX, United States |
| Recall initiated | 2021-10-12 |
| Classified | 2021-11-08 |
| Reported by FDA | 2021-11-17 |
| Terminated | 2023-10-04 |
| Distributed | PR, WA |
| Quantity | 2 vials |
| Reason classes | sterility |
| Expiration dates | 2022-01-09 |
Product
TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1.75MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
Reason for recall
Lack of assurance of sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0176-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.